Cargando…
Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
Autores principales: | Hassanipour, Soheil, Arab-Zozani, Morteza, Amani, Bahman, Heidarzad, Forough, Fathalipour, Mohammad, Martinez-de-Hoyo, Rudolph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805134/ https://www.ncbi.nlm.nih.gov/pubmed/35105913 http://dx.doi.org/10.1038/s41598-022-05835-2 |
Ejemplares similares
-
The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
por: Hassanipour, Soheil, et al.
Publicado: (2021) -
Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials
por: Arab-Zozani, Morteza, et al.
Publicado: (2020) -
Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
por: Hassaniazad, Mehdi, et al.
Publicado: (2020) -
Addendum
Publicado: (1985) -
Addendum
Publicado: (1993)